Marlise R. Luskin, MD, MSCE, speaks with Healio about findings from the phase 3 randomized Alliance A041501 trial.The study was put on hold due to grade 5 events among patients who received inotuzumab ...
Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic leukaemia (ALL) patients earlier in their treatment journey.
Coping with a diagnosis of acute lymphoblastic leukaemia (ALL) can be overwhelming. Help and support are available for you and your family. There are things you can do, and specialists who can help ...
Learn about Acute Lymphoblastic Leukemia ALL including its symptoms treatment options and survival rates Expert share insights into life expectancy and the impact of this aggressive cancer on patients ...